Nasdaq · CIK 0001513525
ADIL ADIAL PHARMACEUTICALS, INC.
Insider trading from SEC Form 4. Last filing 22 d ago. Close $3.50 on Oct 12, 2026, +157% from the 52-week low and -64% from the high.
In brief
ADIAL PHARMACEUTICALS, INC. (ADIL) has 21 SEC Form 4 filings on file from 10 insiders, the latest filed on Sep 21, 2026. In the last 90 days insiders made 1 open-market buy worth $8,691 and 0 open-market sells worth $0, net +$8,691.
3 open-market trades have been scored at ADIL. The newest: Coastlands Capital LP (10% owner) bought $8,691 of stock on Jul 14, 2026, filed Jul 16, 2026, scored 7 (weak). The largest of the 3 shown: Coastlands Capital LP (10% owner) bought $65k on Jun 29, 2026, scored 18 (weak).
Last 90 days
Price and insider trades, last year
Daily candles, adjusted for splits and dividends. Green arrows are insider buys, red are sells, sized by value. Click a marked bar to open the signal.Charts by TradingView Lightweight Charts™
Signals
Open-market buys and sells at ADIAL PHARMACEUTICALS, INC., scored.
| Score | Insider | Value | Holdings | Price context | Filed |
|---|---|---|---|---|---|
| 7Weak | Coastlands Capital LP owner buy | $8,691 3,233 shares | +1% | - | |
| 18Weak | Coastlands Capital LP owner buy | $33k 11,753 shares | +3% | - | |
| 18Weak | Coastlands Capital LP owner buy | $65k 25,000 shares | +7% | - |
Transactions
Every row filed, 28 in all.
| Date | Insider | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Sep 17, 2026 | Wendy B. Young director | AGrant or award Stock Option (Right to Buy)derivative | +25,666 | $0.00 | $0 | 25,666 | 22 d ago |
| Jul 14, 2026 | Coastlands Capital LP owner | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +2,000 | $2.65 | $5,300 | 387,075 | Jul 16, 2026 |
| Jul 16, 2026 | Coastlands Capital LP owner | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +1,233 | $2.75 | $3,391 | 388,308 | Jul 16, 2026 |
| Jul 9, 2026 | Coastlands Capital LP owner | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +10,053 | $2.79 | $28k | 383,375 | Jul 13, 2026 |
| Jul 10, 2026 | Coastlands Capital LP owner | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +1,700 | $2.70 | $4,590 | 385,075 | Jul 13, 2026 |
| Jun 29, 2026 | Coastlands Capital LP owner | POpen-market purchase Common Stockindirect: By Coastlands Capital LP | +25,000 | $2.60 | $65k | 373,322 | Jul 1, 2026 |
| Jun 12, 2026 | Wendy B. Young director | POpen-market purchase Pre-funded Warrantderivative | +36,378 | $2.75 | $100k | 36,378 | Jun 16, 2026 |
| Jun 11, 2026 | Matt Davidson Chief Development Officer | AGrant or award Common Stock | +61,647 | - | - | 61,647 | Jun 16, 2026 |
| Jun 11, 2026 | Matt Davidson Chief Development Officer | AGrant or award Common Stockindirect: By Matt and Alli Davidson Trust | +3,427 | - | - | 3,427 | Jun 16, 2026 |
| Jun 12, 2026 | Matt Davidson Chief Development Officer | AGrant or award Common Stock | +232,417 | $0.00 | $0 | 297,491 | Jun 16, 2026 |
| Jun 11, 2026 | Matt Davidson Chief Development Officer | AGrant or award Series A Preferred Stock | +1,822 | - | - | 1,822 | Jun 16, 2026 |
| Jun 11, 2026 | Matt Davidson Chief Development Officer | AGrant or award Series A Preferred Stockindirect: By Matt and Alli Davidson Trust | +101 | - | - | 1,923 | Jun 16, 2026 |
| Jun 12, 2026 | Matt Davidson Chief Development Officer | AGrant or award Stock Option (Right to Buy)derivative | +232,417 | $0.00 | $0 | 232,417 | Jun 16, 2026 |
| Apr 7, 2026 | Robertson H. Gilliland director | AGrant or award Common Stock | +9,185 | $0.00 | $0 | 9,185 | Apr 9, 2026 |
| Apr 7, 2026 | J. Kermit Anderson director | AGrant or award Stock Option (Right to Buy)derivative | +9,185 | $0.00 | $0 | 9,185 | Apr 9, 2026 |
| Apr 7, 2026 | Tony Goodman Chief Operating Officer | AGrant or award Common Stock | +26,510 | $0.00 | $0 | 26,523 | Apr 9, 2026 |
| Apr 7, 2026 | Vinay Shah Chief Financial Officer | AGrant or award Common Stock | +17,325 | $0.00 | $0 | 17,325 | Apr 9, 2026 |
| Apr 7, 2026 | Kevin Schuyler director | AGrant or award Common Stock | +9,185 | $0.00 | $0 | 9,213 | Apr 9, 2026 |
| Apr 7, 2026 | Cary J Claiborne Chief Executive Officer | AGrant or award Common Stock | +37,985 | $0.00 | $0 | 40,417 | Apr 9, 2026 |
| May 29, 2025 | J. Kermit Anderson director | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
| May 29, 2025 | Tony Goodman Chief Operating Officer | AGrant or award Stock Option (Right to Buy)derivative | +94,000 | $0.00 | $0 | 94,000 | Jun 2, 2025 |
| May 29, 2025 | Cary J Claiborne Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +138,000 | $0.00 | $0 | 138,000 | Jun 2, 2025 |
| May 29, 2025 | Kevin Schuyler director | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
| May 29, 2025 | Vinay Shah Chief Financial Officer | AGrant or award Stock Option (Right to Buy)derivative | +9,000 | $0.00 | $0 | 9,000 | Jun 2, 2025 |
| May 29, 2025 | James W. Newman Jr. director | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
| May 29, 2025 | Robertson H. Gilliland director | AGrant or award Stock Option (Right to Buy)derivative | +28,000 | $0.00 | $0 | 28,000 | Jun 2, 2025 |
| Dec 5, 2024 | Cary J Claiborne Chief Executive Officer | AGrant or award Stock Option (Right to Buy)derivative | +350,000 | $0.00 | $0 | 350,000 | Dec 5, 2024 |
| Nov 16, 2024 | Vinay Shah Chief Financial Officer | AGrant or award Stock Optionderivative | +40,000 | $0.00 | $0 | 40,000 | Nov 18, 2024 |
Insiders
Everyone who has filed a Form 4 here.
- J. Kermit Andersondirector
- Cary J ClaiborneChief Executive Officer
- Coastlands Capital LPowner
- Matt DavidsonChief Development Officer
- Robertson H. Gillilanddirector
- Tony GoodmanChief Operating Officer
- James W. Newman Jr.director
- Kevin Schuylerdirector
- Vinay ShahChief Financial Officer
- Wendy B. Youngdirector
Questions about ADIL
Answered from the filings on this page, as of the latest one.
Are insiders buying ADIL?
As of Sep 21, 2026, SEC Form 4 filings show 1 open-market buy worth $8,691 by 1 insider and 0 open-market sells worth $0 by 0 insiders at ADIAL PHARMACEUTICALS, INC. in the last 90 days, net +$8,691. Only purchases (code P) and sales (code S) count; grants, option exercises and tax withholding do not.
Who was the last insider to trade ADIL on the open market?
Coastlands Capital LP (10% owner) bought $8,691 of ADIL on Jul 14, 2026 and filed the Form 4 on Jul 16, 2026. InsiderTell scored 7 (weak).
How many insiders file Form 4 at ADIAL PHARMACEUTICALS, INC.?
10 people have filed a Form 4 at ADIAL PHARMACEUTICALS, INC., among them J. Kermit Anderson (director), Cary J Claiborne (Chief Executive Officer), Coastlands Capital LP (10% owner). Officers, directors and holders of more than 10% of a share class must report their trades within two business days.
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.